Denali Therapeutics Inc.
Hedge Funds Holdings
Last updated:
Denali Therapeutics Inc.‘s stocks are currently a part of 117 hedge funds’ portfolios, which represents 45.15% of the total amount of its stocks outstanding. This makes up a total of 56.67M shares of Denali Therapeutics Inc.. Compared to the previous quarter, the number fell by -46.40% or -49.05M shares fewer. As for the holding position changes, 48.72% (57) of current hedge fund investors increased the number of shares held, 23.08% (27) of current holders sold a part of the shares held, and 10.26% (12) closed the holdings completely. 11 hedge funds are new holders of Denali Therapeutics Inc. stock in Q1 2023, it is 9.4% of total holders.
Hedge funds holding Denali Therapeutics (Q2 2018 – Q1 2023)
| Q2 2018 | 66 |
|---|---|
| Q3 2018 | 77 |
| Q4 2018 | 88 |
| Q1 2019 | 112 |
| Q2 2019 | 112 |
| Q3 2019 | 113 |
| Q4 2019 | 106 |
| Q1 2020 | 125 |
| Q2 2020 | 142 |
| Q3 2020 | 167 |
| Q4 2020 | 200 |
| Q1 2021 | 213 |
| Q2 2021 | 205 |
| Q3 2021 | 206 |
| Q4 2021 | 204 |
| Q1 2022 | 176 |
| Q2 2022 | 174 |
| Q3 2022 | 188 |
| Q4 2022 | 193 |
| Q1 2023 | 117 |
Hedge funds changes in Denali Therapeutics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 16 | 29 | 13 | 8 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 19 | 38 | 11 | 8 | 1 |
| Q4 2018 | 24 | 34 | 22 | 13 | -5 |
| Q1 2019 | 31 | 35 | 26 | 7 | 13 |
| Q2 2019 | 23 | 41 | 23 | 21 | 4 |
| Q3 2019 | 15 | 38 | 24 | 14 | 22 |
| Q4 2019 | 14 | 30 | 38 | 16 | 8 |
| Q1 2020 | 34 | 53 | 20 | 13 | 5 |
| Q2 2020 | 32 | 54 | 36 | 14 | 6 |
| Q3 2020 | 43 | 54 | 48 | 17 | 5 |
| Q4 2020 | 58 | 61 | 66 | 24 | -9 |
| Q1 2021 | 42 | 77 | 68 | 26 | 0 |
| Q2 2021 | 33 | 80 | 59 | 40 | -7 |
| Q3 2021 | 35 | 80 | 62 | 32 | -3 |
| Q4 2021 | 26 | 84 | 60 | 26 | 8 |
| Q1 2022 | 16 | 65 | 63 | 44 | -12 |
| Q2 2022 | 23 | 67 | 53 | 20 | 11 |
| Q3 2022 | 31 | 74 | 55 | 17 | 11 |
| Q4 2022 | 30 | 83 | 51 | 25 | 4 |
| Q1 2023 | 11 | 57 | 27 | 12 | 10 |
Hedge funds changes in Denali Therapeutics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 12,000 | 191,000 |
|---|---|---|
| Q3 2018 | 7,000 | 0 |
| Q4 2018 | 0 | 2,000 |
| Q1 2019 | 48,000 | 2,000 |
| Q2 2019 | 1,059,000 | 328,000 |
| Q3 2019 | 871,000 | 1,754,000 |
| Q4 2019 | 1,243,000 | 920,000 |
| Q1 2020 | 367,000 | 483,000 |
| Q2 2020 | 837,000 | 324,000 |
| Q3 2020 | 2,084,000 | 2,547,000 |
| Q4 2020 | 29,297,000 | 5,764,000 |
| Q1 2021 | 14,442,000 | 4,850,000 |
| Q2 2021 | 30,026,000 | 7,695,000 |
| Q3 2021 | 12,403,000 | 5,192,000 |
| Q4 2021 | 2,599,000 | 11,283,000 |
| Q1 2022 | 818,000 | 1,804,000 |
| Q2 2022 | 1,816,000 | 561,000 |
| Q3 2022 | 3,051,000 | 506,000 |
| Q4 2022 | 1,932,418 | 270,290 |
| Q1 2023 | 135,000 | 1,810,998,000 |